General Information of the Compound
| Compound ID |
CP0385993
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-(2,6-diphenylpyrimidin-4-yl)-2-methylbutanamide
Show/Hide
|
||||||||||||||||||
| Synonyms |
820961-47-5
AKOS030569390
BDBM50157656
Butanamide, N-(2,6-diphenyl-4-pyrimidinyl)-2-methyl-
CHEMBL223977
CTK3E2656
DTXSID70465602
L023253
LUF-5767
N-(2,6-diphenylpyrimidin-4-yl)-2-methylbutyramide
SCHEMBL4829114
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C21H21N3O
|
||||||||||||||||||
| Molecular Weight |
331.419
|
||||||||||||||||||
| Canonical SMILES |
CCC(C)C(=O)Nc1cc(nc(n1)-c1ccccc1)-c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C21H21N3O/c1-3-15(2)21(25)24-19-14-18(16-10-6-4-7-11-16)22-20(23-19)17-12-8-5-9-13-17/h4-15H,3H2,1-2H3,(H,22,23,24,25)
Show/Hide
|
||||||||||||||||||
| InChIKey |
OWPSSUJQRJLQHE-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00840, Adenosine receptor A1
Protein ID: PT00862, Adenosine receptor A2a
Protein ID: PT01279, Adenosine receptor A3
Clinical Information about the Compound